Genotyping is the process of determining differences in an individual's genetic makeup by examining the individual's DNA sequence using biological assays and comparing it to another individual's sequence or a reference sequence. Pharmacogenomics tests performed prior to drug treatment are known to reduce overall medical costs and provide a higher quality of life and a longer life expectancy. However, we still need an accurate demonstration that PG testing offers added value, in terms of relative cost and benefit. The utility of the variants in clinical practice depends on improving the diagnostic prediction or promoting changes in prevention or treatment strategies. There is an urgent need for detailed and extensive studies to establish the cost and effectiveness of genotyping. Although there are still unanswered questions, PG researchers have generated and improved specific tools for the novel treatment and management of cancer patients. With the new PG markers identified and validated, clinicians will have ways and means to tailor specific medications to individual genetic profiles. In the coming years, the emergence of molecular resistance to new therapies as a result of genomic abnormalities in cancer will drive diagnostic companies to develop new tests for individualized therapy. The future implementation of genotyping methods will lead to personalized treatment and will eventually shift the balance of disease relapse towards disease eradication. Therefore, it is essential that biotech and pharmaceutical companies join efforts to develop accurate and inexpensive tests for routine diagnosis in pharmacogenomics. (Angela De Monaco, Massimiliano Berretta, Sergio Pugliese, Daniela Valente and Raffaele Di Francia, Early Summary Assessment of Pharmacogenomics Genotyping Costs)
Book Review: Human Genetics & Embryology
Book Review: Human Genetics & Embryology
Research Article: Human Genetics & Embryology
Research Article: Human Genetics & Embryology
Review Article: Human Genetics & Embryology
Review Article: Human Genetics & Embryology
Commentary: Human Genetics & Embryology
Commentary: Human Genetics & Embryology
Scientific Tracks Abstracts: Journal of Molecular Biomarkers & Diagnosis
Scientific Tracks Abstracts: Molecular Biomarkers & Diagnosis
Keynote: Molecular and Genetic Medicine
Keynote: Molecular and Genetic Medicine
AcceptedAbstracts: Journal of Molecular Biomarkers & Diagnosis
AcceptedAbstracts: Molecular Biomarkers & Diagnosis
Scientific Tracks Abstracts: Journal of Tissue Science and Engineering
Scientific Tracks Abstracts: Journal of Tissue Science and Engineering
Human Genetics & Embryology received 309 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 